Impact of customer integration on project portfolio management and its success—Developing a conceptual framework von Voss, Martin

Volltext

Towards individualized therapy for metastatic renal cell carcinoma von Kotecha, Ritesh R., Motzer, Robert J., Voss, Martin H.

Volltext

Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma von Vuong, Lynda, Kotecha, Ritesh R, Voss, Martin H, Hakimi, A Ari

Volltext

Up-front Nivolumab With or Without Salvage Ipilimumab Across International Metastatic Database Consortium Risk Groups in Metastatic Clear Cell Renal Cell Carcinoma von Voss, Martin H

Volltext

Decision-making in schizophrenia: A predictive-coding perspective von Sterzer, Philipp, Voss, Martin, Schlagenhauf, Florian, Heinz, Andreas

Volltext

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures von Şenbabaoğlu, Yasin, Gejman, Ron S, Winer, Andrew G, Liu, Ming, Van Allen, Eliezer M, de Velasco, Guillermo, Miao, Diana, Ostrovnaya, Irina, Drill, Esther, Luna, Augustin, Weinhold, Nils, Lee, William, Manley, Brandon J, Khalil, Danny N, Kaffenberger, Samuel D, Chen, Yingbei, Danilova, Ludmila, Voss, Martin H, Coleman, Jonathan A, Russo, Paul, Reuter, Victor E, Chan, Timothy A, Cheng, Emily H, Scheinberg, David A, Li, Ming O, Choueiri, Toni K, Hsieh, James J, Sander, Chris, Hakimi, A Ari

Volltext

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma von Miao, Diana, Margolis, Claire A, Gao, Wenhua, Voss, Martin H, Li, Wei, Martini, Dylan J, Norton, Craig, Bossé, Dominick, Wankowicz, Stephanie M, Cullen, Dana, Horak, Christine, Wind-Rotolo, Megan, Tracy, Adam, Giannakis, Marios, Hodi, Frank Stephen, Drake, Charles G, Ball, Mark W, Allaf, Mohamad E, Snyder, Alexandra, Hellmann, Matthew D, Ho, Thai, Motzer, Robert J, Signoretti, Sabina, Kaelin, Jr, William G, Choueiri, Toni K, Van Allen, Eliezer M

Volltext

Adjuvant Immunotherapy for Kidney Cancer — A New Strategy with New Challenges von Voss, Martin H., Motzer, Robert J.

Volltext

Management of Kidney Cancer Relapse to Adjuvant Pembrolizumab: Early Insights and Questions for a Newly Emerging Space von Voss, Martin H., Motzer, Robert J.

Volltext

Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial von Hakimi, A Ari, Voss, Martin H, Kuo, Fengshen, Sanchez, Alejandro, Liu, Ming, Nixon, Briana G, Vuong, Lynda, Ostrovnaya, Irina, Chen, Ying-Bei, Reuter, Victor, Riaz, Nadeem, Cheng, Yuan, Patel, Parul, Marker, Mahtab, Reising, Albert, Li, Ming O, Chan, Timothy A, Motzer, Robert J

Volltext

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT... von Pal, Sumanta Kumar, Albiges, Laurence, Tomczak, Piotr, Suárez, Cristina, Voss, Martin H, de Velasco, Guillermo, Chahoud, Jad, Mochalova, Anastasia, Procopio, Giuseppe, Mahammedi, Hakim, Zengerling, Friedemann, Kim, Chan, Osawa, Takahiro, Angel, Martín, Gupta, Suyasha, Khan, Omara, Bergthold, Guillaume, Liu, Bo, Kalaitzidou, Melania, Huseni, Mahrukh, Scheffold, Christian, Powles, Thomas, Choueiri, Toni K

Volltext

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3‐Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma von Carlo, Maria I., Molina, Ana M., Lakhman, Yulia, Patil, Sujata, Woo, Kaitlin, DeLuca, John, Lee, Chung‐Han, Hsieh, James J., Feldman, Darren R., Motzer, Robert J., Voss, Martin H.

Volltext

The experience of agency: an interplay between prediction and postdiction von Synofzik, Matthis, Vosgerau, Gottfried, Voss, Martin

Volltext

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) von Rini, Brian I., Battle, Dena, Figlin, Robert A., George, Daniel J., Hammers, Hans, Hutson, Tom, Jonasch, Eric, Joseph, Richard W., McDermott, David F., Motzer, Robert J., Pal, Sumanta K., Pantuck, Allan J., Quinn, David I., Seery, Virginia, Voss, Martin H., Wood, Christopher G., Wood, Laura S., Atkins, Michael B.

Volltext

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer von Hellmann, Matthew D., Nathanson, Tavi, Rizvi, Hira, Creelan, Benjamin C., Sanchez-Vega, Francisco, Ahuja, Arun, Ni, Ai, Novik, Jacki B., Mangarin, Levi M.B., Abu-Akeel, Mohsen, Liu, Cailian, Sauter, Jennifer L., Rekhtman, Natasha, Chang, Eliza, Callahan, Margaret K., Chaft, Jamie E., Voss, Martin H., Tenet, Megan, Li, Xue-Mei, Covello, Kelly, Renninger, Andrea, Vitazka, Patrik, Geese, William J., Borghaei, Hossein, Rudin, Charles M., Antonia, Scott J., Swanton, Charles, Hammerbacher, Jeff, Merghoub, Taha, McGranahan, Nicholas, Snyder, Alexandra, Wolchok, Jedd D.

Volltext

Novel emerging biomarkers to immunotherapy in kidney cancer von Ged, Yasser, Voss, Martin H.

Volltext

Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study von Sanchez, Alejandro, Furberg, Helena, Kuo, Fengshen, Vuong, Lynda, Ged, Yasser, Patil, Sujata, Ostrovnaya, Irina, Petruzella, Stacey, Reising, Albert, Patel, Parul, Mano, Roy, Coleman, Jonathan, Russo, Paul, Liu, Catherine H, Dannenberg, Andrew J, Chan, Timothy A, Motzer, Robert, Voss, Martin H, Hakimi, A Ari

Volltext

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates von Lee, Chung-Han, Voss, Martin H, Carlo, Maria Isabel, Chen, Ying-Bei, Zucker, Mark, Knezevic, Andrea, Lefkowitz, Robert A, Shapnik, Natalie, Dadoun, Chloe, Reznik, Ed, Shah, Neil J, Owens, Colette Ngozi, McHugh, Deaglan Joseph, Aggen, David Henry, Laccetti, Andrew Leonard, Kotecha, Ritesh, Feldman, Darren R, Motzer, Robert J

Volltext

Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study von Hammers, Hans J, Plimack, Elizabeth R, Infante, Jeffrey R, Rini, Brian I, McDermott, David F, Lewis, Lionel D, Voss, Martin H, Sharma, Padmanee, Pal, Sumanta K, Razak, Albiruni R Abdul, Kollmannsberger, Christian, Heng, Daniel Y C, Spratlin, Jennifer, McHenry, M Brent, Amin, Asim

Volltext

Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation? von Voss, Martin, Kotrba, Johanna, Gaffal, Evelyn, Katsoulis-Dimitriou, Konstantinos, Dudeck, Anne

Volltext